The failure of HIV-1 to escape at some cytotoxic T-lymphocyte (CTL) epitopes has generally been explained in terms of viral fitness costs or ineffective or attenuated CTL responses. Relatively little attention has been paid to the evolutionary time required for escape mutants to be detected. This time is significantly affected by selection, mutation rates, the presence of other advantageous mutations, and the effective population size of HIV-1 in vivo (typically estimated to be¨10 3 in chronically infected patients, though one study has estimated it to be¨10 5 ).
Introduction CD8+ cytotoxic T-lymphocyte (CTL) responses are associated with control of HIV-1 infection (Borrow et al., 1994; Koup et al., 1994; Ogg et al., 1998 ), yet they rarely, if ever, clear the infection. CTL escape, mediated by changes in reactive viral epitopes or peptide processing, is an important mechanism by which HIV-1 evades clearance (Borrow et al., 1997; Moore et al., 2002; Price et al., 1997; Wolinsky et al., 1996) . CTL escape mutants have been reported to appear within a couple months after HIV-1 infection (Borrow et al., 1997; Cao et al., 2003) , indicating that CTL can be a strong selective force influencing the evolution of HIV-1 in vivo. The failure to observe escape mutations at some epitopes has led to the conclusions that certain CTL responses do not exert significant selective pressure (Brander et al., 1998; Hay et al., 1999; Meyerhans et al., 1991; Nietfield et al., 1995; Safrit et al., 1994) and that escape mutants have lower fitness (Goulder and Watkins, 2004; Leslie et al., 2005; Yang et al., 2003) . However, other events that may delay the time to the appearance of selectively advantageous mutants are rarely mentioned.
Here, we used a forward simulator that makes standard population genetics assumptions (e.g., constant population size, no subdivision, constant selection, discrete generations, and no recombination) to estimate the time required for an advantageous CTL escape mutant to be observed. Using this model, we demonstrate the contribution of stochastic mutational effects (Frost et al., 2000; Rouzine and Coffin, 1999) , genetic drift (Brown, 1997) , selection strength, sampling limitations, and clonal interference (Gerrish and Lenski, 1998) to these delays. We also discuss the effects of various violation of modeling assumptions (e.g., fluctuating population sizes) on these delays. For typical sampling schemes and experimentally estimated HIV-1 parameters, we find that these delay times can be very long.
Results
The time required for an advantageous HIV-1 mutant to reach a given frequency As illustrated in Fig. 1 , advantageous mutations occur at random. These mutants are either rapidly lost (due to drift) or fixed. The time (t f ) it takes for an advantageous mutant that ultimately becomes fixed, M adv , to reach a given frequency ( f) after infection will be the sum of the time for its occurrence, t adv , and the time for it to reach f afterwards.
The time required for an advantageous mutant to reach a given frequency, t f , is a complex function of the effective population size (N e ), the advantageous mutation rate, and the strength of selection. To estimate t f for an advantageous HIV-1 mutant, we conducted forward simulations (Liu et al., 2004) with a constant population size, N = N e , and HIV-1-specific parameter values.
Although one study has reported N e¨1 0 5 for HIV-1 (Frost et al., 2000; Rouzine and Coffin, 1999) , most studies of chronically infected untreated patients have estimated N e to be in the range of 10 3 to 5 Â 10 3 (Brown, 1997; Seo et al., 2002; Shriner et al., 2004b) , including subsequent work that includes the co-author that reported N e¨1 0 5 (Achaz et al., 2004) . The average nucleotide mutation rate of HIV-1, l, has been estimated to be¨2.5 Â 10 À5 per nucleotide per generation in vitro (Mansky, 1996) . Suppose that mutations occur with equal probability among all four nucleotides and that the four nucleotides occur with equal frequency. If only one amino acid site is involved in the mutational escape of an epitope, a nonzero advantageous mutation rate, l adv , for the epitope will be between l/3 and 3l. If mutations at multiple sites in an epitope can lead to escape, l adv of the epitope can be larger.
The kinetics of appearance of a mutant is strongly affected by the effective population size ( Fig. 2A ). For N e of the order of 10 3 , random drift plays an important role. The time required to observe advantageous mutants is largely determined by the waiting time for the occurrence of an advantageous mutation that eventually becomes fixed, t adv . For an amino acid site of HIV-1 with an advantageous mutation rate of l adv = l/3, and a selection coefficient of s = 0.1, over half of the time for the M adv to reach 50% (t 50% ), is taken by t adv . For N (=N e ) = 10 3 , t 50% ranged from¨100 to over 10 3 generations, with a median of 511, or about 2 years, given estimates for the HIV-1 generation time ranging from 1.2 to 2.6 days (Fu, 2001; Markowitz et al., 2003; Mittler et al., 1999; Perelson et al., 1996; Rodrigo et al., 1999) . When N (=N e ) = 5 Â 10 3 , the median t 50% declined to 170 generations. For a very large population of N (=N e ) = 10 5 , advantageous mutations occur almost every generation. In this case, evolution is largely deterministic (Rouzine and Coffin, 1999) and the time required for M adv to occur contributes little to t f . For N (=Ne) = 10 5 and an amino acid site of HIV-1 with l adv = l/3 and s = 0.1, the waiting time for M adv to appear was just a few days, and it took about half a year for the advantageous mutant to reach a frequency of 50%.
Mutation and selection also affect the appearance of advantageous mutants (Fig. 2B ). Random drift exerts stronger effects when advantageous mutation rates and selection coefficients are low. For N (=N e ) = 10 3 and an amino acid site of HIV-1 with s = 0.01, the range of t 50% was 198 to¨10 6 generations (median = 5808) for l adv = l/3, and 183 to¨10 3 generations (median = 876) for l adv = 3A. On the other hand, for a site with s = 0.5, the range of t 50% was 20 to 845 generations (median = 169) for l adv = l/3, and 15 to 144 generations (median = 34) for l adv = 3A. Although t 50% is a nonlinear function of l, s, and N e , for the specific combination of parameters N e = 10 3 , l adv = l/3, l = 2.5 Â 10 À5 , and s = 0.1, 5-fold increases in s, l adv , and N e all decreased medium t 50% by about the same amount (3.02, 3.4, and 3.01, respectively).
The probability of observing advantageous mutants over time using standard sampling techniques
Here, we consider cases in which only one amino acid site is under positive selection. To estimate this probability in populations of N (=N e ) = 10 3 , we conducted forward simulations with 10 viral sequences sampled at a time, as is commonly done in viral evolution studies. As shown in Figs. 3A and B, advantageous mutants can emerge rapidly. For sites with l adv = 3A and s ! 0.01, or sites with l adv = l/3 and s ! 0.1, it is not unusual (>5% likelihood) to observe at least one (!10%) advantageous mutant within 100 generations (¨0.5 year) after infection. However, after 500 generations, about 2 years of infection, an advantageous mutant with l adv = l/3 and s = 0.5 still has a 10% chance of remaining undetected. For an advantageous amino acid mutant with l adv = l/3 and s = 0.1, the chance of remaining undetected is 5.5%, even after 2000 generations (¨10 years of infection).
For a very large N (=N e ) = 10 5 , evolution is almost deterministic and we could estimate this probability from frequency changes obtained from our model (see Materials and methods). As shown in Fig. 3C , with a sample size of 10, and Fig. 1 . Schematic representation of the frequency dynamics of an advantageous mutant. Some of these mutations will be lost due to stochastic forces (illustrated here by lines not reaching a 0.01 frequency). t adv is the time required for the occurrence of an advantageous mutant that accumulates and eventually becomes fixed (M adv ). t 50% is the time after infection required for an advantageous mutant to expand to compose 50% of the population. t 100% is the time after infection required for an advantageous mutant to become fixed.
for an amino acid site with l adv = l/3 and s = 0.1, the probability of observing an advantageous mutant increases rapidly over time. However, before 100 generations have elapsed (¨0.5 years of infection), the probability of observing over five advantageous mutants in a sample of 10 (!50%) is less than 70%. For an amino acid site with l adv = l/3 and s = 0.01, out of 10 samples, the probability of observing no advantageous mutants within 400 generations (¨2 years) is over 50%.
The effect of competition between multiple advantageous mutants
The accumulation of one advantageous mutant can be suppressed by other competing advantageous mutants, especially when other mutants have higher fitness (Gerrish and Lenski, 1998; Kim and Stephan, 2003; Miralles et al., 1999) , although this may be relaxed by frequent recombination in HIV-1 (Shriner et al., 2004a; Zhuang et al., 2002) . To evaluate this suppressive effect (known as clonal interference), we performed simulations with six linked amino acid sites under positive selection, each having l adv = l/3. The CTL escape mutant was given s = 0.1, while each of the other five competing sites was given s = 0.2. For N = 10 3 , the probability of observing no advantageous mutants at the site of interest within the first 2000 generations increases from 5.5% in the absence of competing mutants to 15% with five other sites under stronger positive selection (Fig. 4A ). For N = 10 5 , within the first 300 generations, we observed no advantageous mutants at the site of interest in 60% (12 out of 20) of our simulations.
Discussion
The selective advantage of a CTL escape mutant of HIV-1 is determined by the balance between the beneficial effect of evading the corresponding CTL responses and the fitness costs associated with having an altered protein. When the antiviral effect of the corresponding CTL response is insignificant, the advantage of escape is low. Alternatively, when an escape mutation disrupts the key structure or function of the virus, it can impose a replication fitness cost that may exceed the benefit of escaping the CTL response. Small antiviral effects and high fitness costs, therefore, can delay or prevent the emergence of CTL escape mutants. Emergence of these mutants can also be delayed by stochastic forces, such as mutational bottlenecks, genetic drift, and competition from other advantageous mutants in the population. However, these forces are rarely mentioned when discussing the failure to observe CTL escape mutants in vivo. In this study, we showed that, with the best available estimates of effective population size in chronically infected patients (¨10 3 ), the time to appearance of selectively advantageous HIV-1 CTL escape mutant(s) in chronically infected patients can be several years, even with strong selective pressure.
We used published estimates for N e and l as the starting point for our investigations. For N e = 10 3 , l adv = l/3, l = 2.5 Â 10 À5 , and s = 0.1, we found that 5-fold increases in N e , the Fig. 2 . The time, in generations, required for the occurrence of an advantageous HIV-1 mutation that is eventually fixed (t adv ), and to reach 50% (t 50% ) level in the population after infection. (A) t adv and t 50% for advantageous mutants at one amino acid site under positive selection with l adv = l/3 (l = 2.5 Â 10 À5 ); s = 0.1; and N = 10 3 , 2 Â 10 3 , 3 Â 10 3 , 4 Â 10 3 , 5 Â 10 3 , 10 4 , or 10 5 . (B) t adv and t 50% for advantageous mutants at one amino acid site under positive selection with N = 10 3 , l adv = l/3 or 3l; and s = 0.01, 0.1, or 0.5. Bars and boxes give the minimum, the 25th percentile, the median, the 75th percentile, and the maximum, out of 100 replicates. advantageous mutation rate, l adv , and the selective advantage of the mutant, s, all decrease the evolutionary time for escape mutants to be detected by comparable amounts (¨3-fold), though for larger values of N e s has a bigger effect on t 50% than l (Coffin, 1995) . Although most studies (Achaz et al., 2004; Brown, 1997; Seo et al., 2002; Shriner et al., 2004b) suggest that N e¨1 0 3 , Rouzine and Coffin (1999) have estimated N e to be¨10 5 . However, Shriner et al. (2004b) have argued that Rouzine and Coffin's estimate of N e is¨35-fold too high due to a biased sampling procedure and the incorporation of an incorrect mutation rate. Nonetheless, even with N e = 10 5 , an advantageous mutant with s = 0.1 will still take about 100 generations (¨0.5 year) to reach a frequency of 50%.
We note that all of the estimates of N e are based on sequences obtained from chronically infected patients. In primary infection, N e for HIV-1 is likely to be much higher since these patients often have very high viral loads and a large pool of CD4+ T-lymphocyte target cells (Mehandru et al., 2004) . Given the strong dependence of t 50% on N e , our model suggests that escape mutants of CTL epitopes recognized during primary infection can rise rapidly in patients. However, many epitopes are recognized during chronic infection. Because viral loads decline following the resolution of the primary infection, the absolute number of viruses carrying advantageous mutants that are not immediately selected will decline as primary infection resolves. These mutants can subsequently be lost due to drift during the chronic phase of infection.
Another criticism of estimates of N e¨1 0 3 is that it may be inappropriate to apply neutral models to populations that are subject to strong selection. For example, it is possible that these estimates of N e are low because recurrent selection periodically purges the population of genetic variation. However, if recurrent selective sweeps are artificially reducing estimates for N e , one would still need to account for these sweeps when calculating the time to appearance of a CTL escape mutant. Our simulations show that even with a simulated population size of N = 10 5 that a moderately advantageous escape mutant (s = 0.1) may still take¨2 years to be detected if it has to compete with other more advantageous mutants. Thus, potential errors in the calculation or interpretation of N e due to selection do not necessarily mean that the times to appearance of CTL escape mutants will be short.
Our model also assumes constant population size, no subdivision, discrete generations, no latent infection, constant selection, no recombination, and no dual or superinfection. Population fluctuations and subdivision generally reduce effective population sizes, which would most likely lead to even longer delay times. Violation of discrete generations and no latently infected cells are unlikely to have a large effect on our calculations since HIV-1 turns over rapidly (Liu et al., 2004; Ramratnam et al., 1999) and because viral production of latently infected cells were minimum compared to productively infected cells. Violation of the constant selection assumption is neutral with respect to our argument: depending on how the selection coefficient changed over time, delay times would change accordingly. Although dual or superinfection could reduce delay times by increasing genetic diversity, only a small proportion of HIV-1 patients are thought to be infected with multiple HIV-1 strains. If recombination rates are high, the delay times given in Fig. 4 would decrease. However, our other results will not be affected by recombination since they focus on only a single locus.
In this study, we only examined advantageous mutants requiring a single nucleotide mutation. For advantageous mutants that require multiple nucleotide mutations to escape or compensatory mutations at other amino acid sites to maintain fitness, the time required for observation will be even longer. In addition, during HIV-1 infection, multiple amino acid sites can be under different selection pressures simultaneously. For example, it is not unusual to observe multiple epitopes eliciting CTL responses at the same time (Cao et al., 2003; Goulder et al., 2001) . As discussed above, our results suggest that competition from other advantageous mutants may also delay the observation of the mutant of interest.
In summary, researchers studying the selective pressures attributable to CTL should not only carefully evaluate the antiviral effect of CTL responses and fitness constraints at CTL epitopes, but also consider the effect of stochastic evolutionary forces on the appearance of escape mutants. Failure to immediately observe CTL escape mutants does not necessarily indicate that CTL is not exerting effects in vivo. While we have focused our efforts on HIV-1 in response to a perceived problem in interpreting CTL escape data, these models are very general: similar delays could occur for other infectious diseases and other kinds of advantageous mutants.
Materials and methods
Estimation of the time required for an HIV-1 advantageous mutant to reach a given frequency To estimate this time, we conducted forward simulations (Liu et al., 2004) , using a Wright -Fisher model (Wright, Fig. 4 . Effect of additional selected sites on the probability of observing at least one (!10%), at least five (!50%), and all 10 (100%) mutants at a site of interest, assuming a sample size of 10 and n additional selected sites. Here, l adv = l/3, s = 0.1 for the mutant of interest, and s = 0.2 for the other advantageous mutants. (A) N = 10 3 ; (B) N = 10 5 . 1931). We assume that there is a constant population size, no subdivision, constant selection, discrete generations, no recombination, no latent infection, and no dual or superinfection. Estimates for the effective population size for HIV-1 in untreated patients, N e , range from¨10 3 (Achaz et al., 2004; Brown, 1997; Seo et al., 2002; Shriner et al., 2004b) tö 10 5 (Frost et al., 2000; Rouzine and Coffin, 1999) . The in vivo advantageous mutation rate, l adv , is related to the average in vivo nucleotide mutation rate, l, which we assume is equal to in vitro estimates of¨2.5 Â 10 À5 mutations per nucleotide per generation (Mansky, 1996) . For simplicity, we assume that any nucleotide can mutate to the other three nucleotides with equal probability and that each site has the same underlying mutation rate, l. With these assumptions, the rate of mutation to a particular nucleotide will be l/3. For a randomly chosen codon, following the genetic code, if mutations at only one amino acid site in an epitope can lead to escape, a nonzero l adv for the epitope will be between l/3 and 3l. Therefore, we simulated initially homogeneous populations with N = 10 3 , 2 Â 10 3 , 3 Â 10 3 , 4 Â 10 3 , 5 Â 10 3 , 10 4 , or 10 5 ; l adv = l/3 or 3l (l = 2.5 Â 10 À5 ); and s = 0.01, 0.1, or 0.5. Frequency changes of the advantageous mutants over time were recorded. One hundred replicates were simulated.
Estimation of the probability of observing advantageous mutants over time
For small effective population sizes, random drift is important for the rise in frequency of advantageous mutants. To quantify the probability of observing advantageous amino acid changes over time, we conducted forward simulations with initially homogeneous population of N = 10 3 and l = 2.5 Â 10 À5 . One amino acid site was under positive selection, with l adv = l/3 or 3l, and s = 0.01, 0.1, or 0.5. Ten samples were collected at generations 100, 200, 500, 1000, and 2000. One thousand replicates were simulated. For a very large population of N = 10 5 , evolution is almost deterministic and the probability of observing advantageous amino acid changes is calculated according to the frequency changes of the advantageous mutants over time, generated by simulations described above. With a sample size of 10, the probability of observing n (0 n 10) advantageous mutants of a given f can be calculated according to a binomial distribution: p 10 n ð Þ ¼ 10 n Â f n Â 1 À f ð Þ 10Àn :
Effect of competition between multiple advantageous mutants
Forward simulations were performed with initially homogeneous population of N = 10 3 or 10 5 and l = 2.5 Â 10 À5 . Six linked amino acid sites were under positive selection, each with l adv = l/3. The site of interest had s = 0.1 and each of the other five competing sites had s = 0.2. The gain of fitness was additive. For N = 10 3 , 10 samples were collected at generations 100, 200, 500, 1000, and 2000. One thousand replicates were simulated. For N = 10 5 , 10 samples were collected at generations 100, 200, 300, 400, and 500. Twenty replicates were simulated.
